Summit Therapeutics Inc (SMMT)
4.43
+0.04
(+0.91%)
USD |
NASDAQ |
May 06, 10:10
Summit Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.4932 |
| March 31, 2022 | 0.389 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.8534 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | |
| March 31, 2020 | 0.00 |
| October 31, 2019 | 0.00 |
| Date | Value |
|---|---|
| July 31, 2019 | 0.00 |
| April 30, 2019 | 0.00 |
| January 31, 2019 | 0.00 |
| October 31, 2018 | 0.00 |
| July 31, 2018 | 0.00 |
| April 30, 2018 | 0.00 |
| January 31, 2018 | 0.00 |
| October 31, 2017 | 0.00 |
| July 31, 2017 | 0.00 |
| April 30, 2017 | 0.00 |
| January 31, 2017 | 0.00 |
| October 31, 2016 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jul 2019
0.8534
Maximum
Mar 2021
0.1446
Average
--
Median
Jul 2019
Debt to Equity Ratio Benchmarks
| Retractable Technologies Inc | 0.0155 |
| BioCardia Inc | 0.00 |
| Alpine Immune Sciences Inc | 0.00 |
| Axsome Therapeutics Inc | 0.9324 |
| Krystal Biotech Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 176.78M |
| Total Liabilities (Quarterly) | 132.57M |
| Shareholders Equity (Quarterly) | 44.21M |